Janani Parameswaran

Janani Parameswaran

Auto-generated profile, based on publicly available information

Janani Parameswaran

Department of Cell Biology, Emory University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2022 in EMBO Reports
Verified
Journal Article
Closed access
DPDevesh C Pant
Devesh C Pant
JPJanani Parameswaran
Janani Parameswaran
LRLu Rao
Lu Rao
ILIsabel Loss
Isabel Loss
GCGanesh Chilukuri
Ganesh Chilukuri
JJJie Jiang
Jie Jiang

19 April 2023 in eLife
Verified
Journal Article
Open access
JPJanani Parameswaran
Janani Parameswaran
NZNancy Zhang
Nancy Zhang
EBElke Braems
Elke Braems
KTKedamawit Tilahun
Kedamawit Tilahun
DPDevesh C Pant
Devesh C Pant
JJJie Jiang
Jie Jiang
GGGGCC (G4C2) hexanucleotide repeat expansion in the C9ORF72 gene is the most common genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The repeat is bidirectionally transcribed and confers gain of toxicity. However, the underlying toxic species is debated, and it is not clear whether antisense CCCCGG (C4G2) repeat expanded RNAs contribute to disease pathogenesis. Our study shows that C9ORF72 antisense C4G2 repeat expanded RNAs trigger the activation of the PKR/eIF2α-dependent integrated stress response independent of dipeptide repeat proteins that are produced through repeat-associated non-AUG-initiated translation, leading to global translation inhibition and stress granule formation. Reducing PKR levels with either siRNA or morpholinos mitigates integrated stress response and toxicity caused by the antisense C4G2 RNAs in cell lines, primary neurons, and zebrafish. Increased phosphorylation of PKR/eIF2α is also observed in the frontal cortex of C9ORF72 FTD/ALS patients. Finally, only antisense C4G2, but not sense G4C2, repeat expanded RNAs robustly activate the PKR/eIF2α pathway and induce aberrant stress granule formation. These results provide a mechanism by which antisense C4G2 repeat expanded RNAs elicit neuronal toxicity in FTD/ALS caused by C9ORF72 repeat expansions.

14 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
BABerna Aliya
Berna Aliya
SLShiqi Liu
Shiqi Liu
AMAlison Mansfield
Alison Mansfield
SYSolan Xiyuan Yao
Solan Xiyuan Yao
SMSabra Mouhi
Sabra Mouhi
JAJimena Andersen
Jimena Andersen
Amyotrophic lateral sclerosis (ALS) is a complex and heterogenous disease, comprising of familial and sporadic forms, numerous genetic mutations, and a wide range of affected cell types and proposed dysregulated processes. While the usage of in vitro cell cultures, mouse models, and postmortem patient tissue have advanced our understanding of ALS disease mechanisms, the temporal progression of the disease and how early molecular changes evolve remain poorly understood. Here, we establish human spinal cord organoids (hSpO) derived from C9orf72 patient induced pluripotent stem cells (C9-ALS hiPSCs) as a platform to model longitudinal changes across the disease trajectory. We show that C9-ALS hSpO recapitulate hallmark C9orf72 -related pathologies, increased cell death, and progressive neuronal dysfunction. We further identify RNA splicing dysregulation as an early and persistent feature of C9-ALS, with splicing signatures in hSpO closely mirroring those observed in postmortem patient tissue. Finally, prediction of RNA binding proteins (RBPs) that induce early splicing changes in C9-ALS reveals signatures consistent with a broad RBP network dysfunction. Together, this work establishes hSpO as an in vitro system for investigating early disease mechanisms of ALS in a human multicellular context and highlights dysregulated events that precede cell death.

9 April 2019 in Neurology
Verified
Journal Article
Closed access
SFStéphane Fourcade
Stéphane Fourcade
JPJanani Parameswaran
Janani Parameswaran
LGLeire Goicoechea
Leire Goicoechea
NLNathalie Launay
Nathalie Launay
MRMontserrat Ruiz
Montserrat Ruiz
APAurora Pujol
Aurora Pujol